Long-Term Cost-Effectiveness Model of Interferon Beta-1b in the Early Treatment of Multiple Sclerosis in the United States. Pan F, Goh J W, Cutter G, Su W, Pleimes D, Wang C Clin Ther. 2012 Aug 17. PMID: 22906738. Abstract CommentRecommendBookmarkWatch